Morgan Stanley’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.78M | Sell |
|
|||||
|
2025
Q1 | $7.42M | Sell |
|
|||||
|
2024
Q4 | $9.71M | Buy |
|
|||||
|
2024
Q3 | $4.08M | Buy |
|
|||||
|
2024
Q2 | $1.85M | Buy |
|
|||||
|
2024
Q1 | $1.73M | Sell |
|
|||||
|
2023
Q4 | $8.42M | Buy |
|
|||||
|
2023
Q3 | $1.78M | Sell |
|
|||||
|
2023
Q2 | $2.21M | Buy |
|
|||||
|
2023
Q1 | $2.24M | Sell |
|
|||||
|
2022
Q4 | $3.55M | Buy |
|
|||||
|
2022
Q3 | $2.25M | Sell |
|
|||||
|
2022
Q2 | $8.46M | Buy |
|
|||||
|
2022
Q1 | $9.18M | Buy |
|
|||||
|
2021
Q4 | $6.2M | Buy |
|
|||||
|
2021
Q3 | $4.48M | Sell |
|
|||||
|
2021
Q2 | $6.21M | Buy |
|
|||||
|
2021
Q1 | $1.28M | Buy |
|
|||||
|
2020
Q4 | $450K | Buy |
|
|||||
|
2020
Q3 | $109K | Sell |
|
|||||
|
2020
Q2 | $205K | Buy |
|
|||||
|
2020
Q1 | $91K | Sell |
|
|||||
|
2019
Q4 | $231K | Buy |
|
|||||
|
2019
Q3 | $137K | Buy |
|
|||||
|
2019
Q2 | $25K | Sell |
|
|||||
|
2019
Q1 | $59K | Buy |
|
|||||
|
2018
Q4 | $12K | Sell |
|
|||||
|
2018
Q3 | $30K | Sell |
|
|||||
|
2018
Q2 | $251K | Buy |
|
|||||
|
2018
Q1 | $260K | Sell |
|
|||||
|
2017
Q4 | $326K | Buy |
|
|||||
|
2017
Q3 | $247K | Buy |
|
|||||
|
2017
Q2 | $294K | Buy |
|
|||||
|
2017
Q1 | $268K | Sell |
|
|||||
|
2016
Q4 | $532K | Buy |
|
|||||
|
2016
Q3 | $34K | Buy |
|
|||||
|
2016
Q2 | $36K | Sell |
|
|||||
|
2016
Q1 | $145K | Sell |
|
|||||
|
2015
Q4 | $738K | Buy |
|